TTP vs Tata Elxsi: full comparison for 2026
Quick verdict
TTP (4.4/5) edges ahead of Tata Elxsi (3.9/5) overall. TTP is the better choice for pharma device programs, inhalers and injectors. Tata Elxsi is the stronger option for large medtech firms offshoring sustaining engineering. The right choice depends on your project size, budget, and required tech stack.
TTP vs Tata Elxsi: head-to-head summary
| Criterion | TTP | Tata Elxsi |
|---|---|---|
| Founded | 1987 | 1989 |
| HQ | Melbourn, Cambridgeshire, UK | Bengaluru, India |
| Team size | Not published | 13,000+ |
| Rating | 4.4 / 5 | 3.9 / 5 |
| Primary differentiator | Employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients | Offshore scale for verification, documentation and sustaining work on existing device portfolios |
| Pricing model | Time and materials, phased fixed project | Time and materials, dedicated team, fixed project |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Ultrasound, Microfluidics, Embedded C/C++ | Embedded C/C++, Embedded Linux, Test automation |
| Industries served | Drug delivery, Surgical & robotics, Diagnostics & lab devices | Surgical & therapeutic devices, Diagnostics & lab devices, Digital health, Automotive |
TTP vs Tata Elxsi: overview
TTP
TTP (The Technology Partnership) has operated for around 40 years from its own science park in Melbourn, South Cambridgeshire. In December 2021 TTP Group moved to 100% employee ownership through an Employee Ownership Trust. Its Medical Devices team works on drug delivery, surgical systems and diagnostics, and the wider company does deep technology work in sectors such as life science instruments and industrial products. Headcount is not published in a form we could verify.
Tata Elxsi
Tata Elxsi is a Tata Group engineering and design company founded in 1989 and headquartered in Bengaluru, with more than 13,000 employees across automotive, media and healthcare. Its medical device practice covers hardware, firmware, mechanical engineering, verification and validation and lifecycle management under an ISO 13485:2016 compliant QMS, and it offers pre-submission support for 510(k) and PMA filings. In 2026 it opened an offshore development center for Terumo in Pune and launched AnaTel, an AI tool for preparing regulatory documents.
Services and capabilities: TTP vs Tata Elxsi
| Capability | TTP | Tata Elxsi |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✓ | ✓ |
| SaMD & companion apps | ✗ | ✓ |
| Connected devices & IoT | ✗ | ✗ |
| Industrial design & human factors | ✗ | ✗ |
| Mechanical engineering | ✓ | ✓ |
| Device cybersecurity | ✗ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✗ | ✗ |
Tech stack comparison: TTP vs Tata Elxsi
| Framework / platform | TTP | Tata Elxsi |
|---|---|---|
| Embedded C/C++ | ✓ | ✓ |
| Embedded Linux | N/A | ✓ |
| RTOS | N/A | N/A |
| BLE | N/A | N/A |
| Cloud (AWS/Azure) | N/A | ✓ |
| IEC 62304 | N/A | ✓ |
| ISO 14971 | N/A | ✓ |
| ISO 13485 QMS | ✓ | N/A |
| Qt | N/A | N/A |
Pricing comparison: TTP vs Tata Elxsi
| Criterion | TTP | Tata Elxsi |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Consulting, Fixed project, Time & materials | Dedicated team, Fixed project, Time & materials |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: TTP vs Tata Elxsi
| Dimension | TTP | Tata Elxsi |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Drug delivery, Surgical & robotics, Diagnostics & lab devices | Surgical & therapeutic devices, Diagnostics & lab devices, Digital health |
| Best use cases | Designing an autoinjector or inhaler for a pharma combination product, Developing a surgical energy device | Sustaining engineering for a portfolio of cleared devices, EU MDR technical file remediation |
| Typical project type | Consulting | Dedicated team |
TTP vs Tata Elxsi: pros and cons
| TTP | |
|---|---|
| + | Employee ownership since 2021 removes pressure from outside investors |
| + | Well regarded for drug delivery devices, an area where mechanics and human factors decide success |
| + | Own science park with lab and workshop space for physical prototyping |
| + | Specialist depth in ultrasound and fluidics |
| - | Does not publish headcount or rates, which makes early budgeting harder |
| - | UK-centric delivery; US clients work across time zones |
| - | Pricing sits with the premium Cambridge consultancies |
| Tata Elxsi | |
|---|---|
| + | Can staff large verification, documentation and sustaining teams |
| + | Offshore development centers for major medtech clients such as Terumo |
| + | Supports 510(k) and PMA preparation |
| + | Lower cost per engineer than Western firms |
| - | Large generalist where healthcare competes with automotive and media for attention |
| - | Better suited to established portfolios than to early-stage invention |
| - | Offshore delivery needs strong client-side technical ownership |
Who should choose TTP?
A typical fit: designing an autoinjector or inhaler for a pharma combination product.
Employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients. Minimum engagement is not publicly disclosed. Works best with clients in Drug delivery, Surgical & robotics, Diagnostics & lab devices.
Who should choose Tata Elxsi?
A typical fit: sustaining engineering for a portfolio of cleared devices.
Offshore scale for verification, documentation and sustaining work on existing device portfolios. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & therapeutic devices, Diagnostics & lab devices, Digital health, Automotive.
Decision matrix: TTP vs Tata Elxsi
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | TTP |
| You need a large dedicated team for an ongoing programme | Tata Elxsi |
| Your budget is at the lower end | Compare: TTP (Not disclosed) vs Tata Elxsi (Not disclosed) |
| You need specialist depth in a specific vertical | Tata Elxsi |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: TTP vs Tata Elxsi
| Use case | TTP fit | Tata Elxsi fit | Winner |
|---|---|---|---|
| Designing an autoinjector or inhaler for a pharma combination product | Strong | Limited | TTP |
| Developing a surgical energy device | Strong | Limited | TTP |
| Sustaining engineering for a portfolio of cleared devices | Limited | Strong | Tata Elxsi |
| EU MDR technical file remediation | Limited | Strong | Tata Elxsi |
Verdict: TTP vs Tata Elxsi
TTP (4.4/5) is the stronger overall choice for most Medical Device Development projects. Employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients.
Tata Elxsi (3.9/5) is worth a look if you need EU MDR technical file remediation. If your situation matches that, Tata Elxsi is a competitive option.
Related comparisons
TTP vs Tata Elxsi FAQ
Is TTP better than Tata Elxsi?
TTP (4.4/5) scores higher overall, but "better" depends on your use case. TTP's strongest advantage: employee ownership since 2021 removes pressure from outside investors. Tata Elxsi's strongest advantage: can staff large verification, documentation and sustaining teams.
How do TTP and Tata Elxsi differ in pricing?
TTP uses time and materials, phased fixed project pricing. Tata Elxsi uses time and materials, dedicated team, fixed project pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: TTP or Tata Elxsi?
Tata Elxsi is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between TTP and Tata Elxsi?
TTP's primary differentiator is: employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients. Tata Elxsi's primary differentiator is: offshore scale for verification, documentation and sustaining work on existing device portfolios. They also differ in team size (Not published vs 13,000+), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Drug delivery, Surgical & robotics vs Surgical & therapeutic devices, Diagnostics & lab devices).
Verify all details directly with each company before making a decision.